Compounds > tetrandrine
Page last updated: 2024-08-25

tetrandrine and Bone Loss, Osteoclastic

tetrandrine has been researched along with Bone Loss, Osteoclastic in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chen, D; Guo, F; Li, Y; Liu, Z; Song, G; Yang, J; Zhang, C1
Dai, Y; Jia, Y; Miao, Y; Shu, M; Wei, Z; Yue, M1
Dai, Y; Jia, Y; Lv, C; Tao, Y; Wei, Z; Xia, Y1
Aburada, M; Kobayashi, S; Nomura, M; Shimada, T; Tachibana, M; Takahashi, T; Tonami, Y1

Other Studies

4 other study(ies) available for tetrandrine and Bone Loss, Osteoclastic

ArticleYear
Tetrandrine Inhibits Titanium Particle-Induced Inflammatory Osteolysis through the Nuclear Factor-
    Mediators of inflammation, 2020, Volume: 2020

    Topics: Animals; Anti-Inflammatory Agents; Benzylisoquinolines; Bone Resorption; Calcium Signaling; Cells, Cultured; Cytokines; Humans; Mice; NF-kappa B; Osteoclasts; Osteolysis; RANK Ligand; RAW 264.7 Cells; Signal Transduction; Titanium

2020
Tetrandrine attenuates the bone erosion in collagen-induced arthritis rats by inhibiting osteoclastogenesis via spleen tyrosine kinase.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2018, Volume: 32, Issue:6

    Topics: Animals; Arthritis, Experimental; Benzylisoquinolines; Bone Resorption; Calcium Signaling; Female; Osteoclasts; Proteolysis; Rats; Rats, Wistar; Syk Kinase; Transcription Factor RelA; Transcription Factors; Ubiquitination

2018
Tetrandrine enhances the ubiquitination and degradation of Syk through an AhR-c-src-c-Cbl pathway and consequently inhibits osteoclastogenesis and bone destruction in arthritis.
    Cell death & disease, 2019, 01-15, Volume: 10, Issue:2

    Topics: Antineoplastic Agents, Phytogenic; Arthritis; Benzylisoquinolines; Bone Resorption; Cell Differentiation; Humans; Osteoclasts; Osteogenesis; Syk Kinase; Ubiquitination

2019
Tetrandrine prevents bone loss in sciatic-neurectomized mice and inhibits receptor activator of nuclear factor κB ligand-induced osteoclast differentiation.
    Biological & pharmaceutical bulletin, 2012, Volume: 35, Issue:10

    Topics: Animals; Benzylisoquinolines; Bone Marrow Cells; Bone Resorption; Cell Differentiation; Cell Line; Cells, Cultured; Drugs, Chinese Herbal; Male; Mice; NFATC Transcription Factors; Osteoclasts; Receptor Activator of Nuclear Factor-kappa B; Sciatic Nerve

2012